BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytivas BioChallenge aims to support the innovation of biotec
PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in. | May 4, 2023
/PRNewswire/ BioCentriq, Inc. and panCELLa, a Pluristyx Company, announced that they have signed a research agreement designed to evaluate the ability of.
provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC).